Intraluminal Administration of Resiniferatoxin Protects against <i>Clostridium difficile</i> Toxin A-Induced Colitis.

Gastroenterol Res Pract · 2017 · PMC5412210 · PMID 28484490

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

We found that RTX given intraluminally one week before toxin A resulted in highly significant inhibition of toxin A-induced luminal fluid accumulation ( Figure 3(a) ), colonic MPO concentration ( Figure 3(b) ), and strong protection against toxin A-induced structural damage to the colon ( Figure 4 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.